State Healthcare Institution "Regional Clinical Cardiology Dispensary"
Saratov, Russian Federation
About State Healthcare Institution "Regional Clinical Cardiology Dispensary"
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at State Healthcare Institution "Regional Clinical Cardiology Dispensary"
During the past decade, State Healthcare Institution "Regional Clinical Cardiology Dispensary" conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
2018-12-04
2023-12-29
Active, not recruiting
128
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "State Healthcare Institution "Regional Clinical Cardiology Dispensary""
#1 collaborator was "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at State Healthcare Institution "Regional Clinical Cardiology Dispensary"
According to Clinical.Site data, the most researched conditions in "State Healthcare Institution "Regional Clinical Cardiology Dispensary"" are
"Heart Failure With Preserved Ejection Fraction" (1 trials) and "Resistant Hypertension" (1 trials). Many other conditions were trialed in "State Healthcare Institution "Regional Clinical Cardiology Dispensary"" in a lesser frequency.
Clinical Trials Intervention Types at State Healthcare Institution "Regional Clinical Cardiology Dispensary"
Most popular intervention types in "State Healthcare Institution "Regional Clinical Cardiology Dispensary"" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Aprocitentan 12.5 mg" (1 trials), "Aprocitentan 25 mg" (1 trials) and "Macitentan" (1 trials). Other intervention names were less common.
Clinical Trials Genders at State Healthcare Institution "Regional Clinical Cardiology Dispensary"
The vast majority of trials in "State Healthcare Institution "Regional Clinical Cardiology Dispensary"" are
2 trials for "All" genders.
Clinical Trials Status at State Healthcare Institution "Regional Clinical Cardiology Dispensary"
Currently, there are NaN active trials in "State Healthcare Institution "Regional Clinical Cardiology Dispensary"".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in State Healthcare Institution "Regional Clinical Cardiology Dispensary",
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in State Healthcare Institution "Regional Clinical Cardiology Dispensary", 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".